XML 36 R10.htm IDEA: XBRL DOCUMENT v3.25.2
DISCONTINUED OPERATIONS
 12 Months Ended
Mar. 31, 2025
Disclosure of analysis of single amount of discontinued operations [abstract]  
DISCONTINUED OPERATIONS DISCONTINUED OPERATIONS
During the fourth quarter of fiscal 2024, the Company closed the sale of its Healthcare business to Madison Industries. At the time of issuance of the consolidated financial statements, the Company is engaged in a dispute with Madison Industries, which is claiming up to approximately $60 million in final price adjustments. For additional information, refer to Note 29.

For the year ended March 31, 2024, the after-tax gain on disposal of the Healthcare business is as follows:
Consideration received in cash$275.3 
Short-term holdback receivable8.0 
Long-term non-contingent receivable10.1 
Total consideration$293.4 
Net assets disposed$269.6 
Impairment of non-financial assets of the disposal group excluded from the sale7.8 
Reclassification to income of gains on foreign currency exchange differences from OCI(2.5)
Transaction fees and other costs12.2 
Gain on disposal of discontinued operations before income taxes$6.3 
Income tax recovery(10.2)
After-tax gain on disposal of discontinued operations$16.5 
The net income and other comprehensive loss from discontinued operations are as follows:

20252024
Revenue$— $131.7 
Expenses— 132.7 
Operating loss$— $(1.0)
Finance expense— 3.6 
Loss before income taxes$— $(4.6)
Income tax recovery— (9.4)
Net income from discontinued operations before after-tax gain on disposal$— $4.8 
After-tax gain on disposal of discontinued operations— 16.5 
Net income from discontinued operations$— $21.3 

For the year ended March 31, 2024, depreciation and amortization of $6.1 million is included in net income from discontinued operations.
20252024
Foreign currency exchange differences on translation of foreign operations$— $0.9 
Reclassification to income of gains on foreign currency exchange differences— (2.5)
Income taxes— (5.4)
Other comprehensive loss from discontinued operations$— $(7.0)
No amount of net income and other comprehensive loss from discontinued operations are attributable to non‑controlling interest.
The major classes of assets and liabilities disposed were as follows:

Current assets
$112.3 
Property, plant and equipment
6.9 
Right-of-use assets
9.8 
Intangible assets, including goodwill of $120.4 million
168.0 
Deferred tax assets
26.5 
Other non-current assets
14.5 
Assets disposed
$338.0 
Current liabilities37.1 
Long-term debt (lease liabilities), including current portion12.2 
Deferred tax liabilities1.4 
Other non-current liabilities
17.7 
Liabilities disposed
$68.4 
Net assets disposed
$269.6 

As a result of the closing of the sale, royalty obligations related to the discontinued operations of $36.9 million previously presented as liabilities held for sale were converted into R&D obligations (Note 21).

The net cash flows from discontinued operations are as follows:
20252024
Operating activities$— $0.4 
Investing activities— 261.6 
Financing activities— (1.3)
Net cash flows provided by discontinued operations$— $260.7